van Doorn PA - Search Results

1

Unmyelinated and myelinated skin nerve damage in Guillain-Barré syndrome: correlation with pain and recovery.

Ruts L, van Doorn PA, Lombardi R, Haasdijk ED, Penza P, Tulen JHM, Hempel RJ, van den Meiracker AH, Lauria G. Ruts L, et al. Among authors: van den meiracker ah, van doorn pa. Pain. 2012 Feb;153(2):399-409. doi: 10.1016/j.pain.2011.10.037. Epub 2011 Dec 10. Pain. 2012. PMID: 22154920

2

Treatment of chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Ruts L. van Doorn PA, et al. Curr Opin Neurol. 2004 Oct;17(5):607-13. doi: 10.1097/00019052-200410000-00011. Curr Opin Neurol. 2004. PMID: 15367865 Review.

3

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.

Ruts L, van Koningsveld R, van Doorn PA. Ruts L, et al. Among authors: van koningsveld r, van doorn pa. Neurology. 2005 Jul 12;65(1):138-40. doi: 10.1212/01.wnl.0000167549.09664.b8. Neurology. 2005. PMID: 16009902

4

Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barré syndrome patients.

Garssen MP, Blok JH, van Doorn PA, Visser GH. Garssen MP, et al. Among authors: van doorn pa. Muscle Nerve. 2006 Feb;33(2):177-82. doi: 10.1002/mus.20451. Muscle Nerve. 2006. PMID: 16270305 Clinical Trial.

5

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. Among authors: van rijs w, van doorn pa. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

6

Contribution of central and peripheral factors to residual fatigue in Guillain-Barré syndrome.

Garssen MP, Schillings ML, Van Doorn PA, Van Engelen BG, Zwarts MJ. Garssen MP, et al. Among authors: van doorn pa, van engelen bg. Muscle Nerve. 2007 Jul;36(1):93-9. doi: 10.1002/mus.20739. Muscle Nerve. 2007. PMID: 17238173

7

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome.

Ruts L, van Koningsveld R, Jacobs BC, van Doorn PA. Ruts L, et al. Among authors: van koningsveld r, van doorn pa. J Neurol. 2007 Oct;254(10):1318-22. doi: 10.1007/s00415-006-0515-2. Epub 2007 Apr 11. J Neurol. 2007. PMID: 17426908 Free PMC article. Clinical Trial.

8

A clinical prognostic scoring system for Guillain-Barré syndrome.

van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC. van Koningsveld R, et al. Among authors: van doorn pa. Lancet Neurol. 2007 Jul;6(7):589-94. doi: 10.1016/S1474-4422(07)70130-8. Lancet Neurol. 2007. PMID: 17537676

9

Origin of ganglioside complex antibodies in Guillain-Barré syndrome.

Kuijf ML, Godschalk PC, Gilbert M, Endtz HP, Tio-Gillen AP, Ang CW, van Doorn PA, Jacobs BC. Kuijf ML, et al. Among authors: van doorn pa. J Neuroimmunol. 2007 Aug;188(1-2):69-73. doi: 10.1016/j.jneuroim.2007.05.014. Epub 2007 Jun 29. J Neuroimmunol. 2007. PMID: 17604126

10

Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.

Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC. Geleijns K, et al. Among authors: van rijs w, van doorn pa. J Neuroimmunol. 2007 Oct;190(1-2):127-30. doi: 10.1016/j.jneuroim.2007.07.008. Epub 2007 Aug 30. J Neuroimmunol. 2007. PMID: 17761309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters